BodammerG.VogtW.: Actions of anaphylatoxin on circulation and respiration of the guinea pig. IntArch. Allergy32 (1967), 417.
2.
BokischV. A.Muller-EberhartH. J.CochraneC. G.: Isolation of a fragment (C3 a) of a third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J. exp. Med.129 (1969), 1109.
3.
LasserE.KolbW. P.LangJ. H.: Contrast media activation of serum complement system. (Letter to the Editor.) InvestRadiol.9:4 (1974), 6 A.
4.
WaltersA.ReuterS.LangJ.: Histamine release by contrast media. InvestRadiol.100 (1971), 683.
5.
GötzeO.Muller-EberhartH. J.: The C3 activator system. An alternative pathway for complement activation. J. exp. Med.134 (1971), 90.
6.
HeidemanM.ClaesG.NilssonA.: The risk of allograft rejection following angiography. Transplantation (In press).
7.
LangeK.GraigF.ObermanJ.SlobodyL.OgurG.LoCastoF.: Changes in serum complement during the course and treatment of glomerulonephritis. Arch, intern. Med.88 (1951), 433.
8.
MayerM. M.: Experimental immunochemistry, p. 115. C. Thomas, Springfield, Illinois1967.
9.
WittenD.: Reactions to urographic contrast media. J. Amer. med. Ass.231 (1975), 974.